Dr. Lerner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6560 Fannin St
Houston, TX 77030Phone+1 713-798-4001Fax+1 713-798-6005
Education & Training
- Baylor College of MedicineResidency, Urology, 1986 - 1990
- Virginia Mason Franciscan HealthResidency, Surgery, 1984 - 1986
- Baylor College of MedicineClass of 1984
Certifications & Licensure
- CA State Medical License 1990 - Present
- TX State Medical License 1985 - 2026
- WA State Medical License 1985 - 1987
- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Super Doctor SuperDoctors.com
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Genetic Susceptibility to Bladder Cancer Start of enrollment: 1998 Feb 10
Publications & Presentations
PubMed
- Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer.Andrea Apolo, Brian C Baumann, Hikmat Al-Ahmadie, Leslie Ballas, Rick Bangs
Bladder Cancer. 2025-02-24 - Impact of Tumor Stage on Oncologic Outcomes of High-grade Bacillus Calmette-Guérin Unresponsive Non-muscle-invasive Bladder Cancer Undergoing Bladder-sparing Therapies.Drupad Annapureddy, Jacob I Taylor, Ashish M Kamat, Michael A O'Donnell, Jeffrey Howard
European Urology Focus. 2025-02-07 - 4 citationsLong-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancer.Jacob I Taylor, Ashish M Kamat, Michael A O'Donnell, Drupad Annapureddy, Jeffrey Howard
BJU International. 2025-02-01
Press Mentions
- Bladder Cancer Trial Finds Extended Lymph Node Surgery Doesn’t Improve SurvivalNovember 6th, 2024
- Extended Lymphadenectomy Does Not Improve DFS or OS Among Patients with Localised Muscle Invasive Bladder CancerNovember 4th, 2024
- Extended Lymphadenectomy Fails to Improve Survival in Bladder CancerOctober 4th, 2024
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: